Biopharmx (BPMX) Short Interest Ratio & Short Volume → The only defense company you should be looking at (From Behind the Markets) (Ad) Free BPMX Stock Alerts $6.12 -0.64 (-9.49%) (As of 05/18/2020) Add Compare Share Share Short InterestStock Analysis Biopharmx Short Interest DataCurrent Short Volume1,090,000 sharesPrevious Short Volume1,170,000 sharesChange Vs. Previous Month-6.84%Dollar Volume Sold Short$555,900.00Short Interest Ratio / Days to Cover0.7Last Record DateApril 30, 2020Outstanding Shares18,278,000 sharesPercentage of Shares Shorted5.96%Today's Trading Volume336,508 sharesAverage Trading Volume2,150,348 sharesToday's Volume Vs. Average16% Short Selling Biopharmx ? Sign up to receive the latest short interest report for Biopharmx and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatBPMX Short Interest Over TimeBPMX Days to Cover Over TimeBPMX Percentage of Float Shorted Over Time Ad Traders Agencytop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall.Click here now for the full details of this stock that’s set to rocket in the AI revolution… Biopharmx Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/20201,090,000 shares $555,900.00 -6.8%N/A0.7 $0.51 4/15/20201,170,000 shares $655,200.00 +12.5%N/A0.9 $0.56 3/31/20201,040,000 shares $322,400.00 +3.9%N/A0.7 $0.31 3/13/20201,000,800 shares $280,224.00 -1.9%N/A0.7 $0.28 2/28/20201,020,000 shares $316,200.00 -22.1%N/A0.7 $0.31 2/14/20201,310,000 shares $484,700.00 -1.5%N/A1 $0.37 1/31/20201,330,000 shares $505,400.00 +106.6%N/A1.1 $0.38 1/15/2020643,700 shares $251,043.00 +29.0%N/A0.7 $0.39 12/31/2019499,200 shares $414,336.00 +45.5%N/A1.1 $0.83 9/15/2019192,400 shares $873,419.04 -19.7%1.4%0.2 $4.54 BPMX Short Interest - Frequently Asked Questions What is Biopharmx's current short interest? Short interest is the volume of Biopharmx shares that have been sold short but have not yet been covered or closed out. As of April 30th, investors have sold 1,090,000 shares of BPMX short. Learn More on Biopharmx's current short interest. What is a good short interest ratio for Biopharmx? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. BPMX shares currently have a short interest ratio of 1.0. Learn More on Biopharmx's short interest ratio. Is Biopharmx's short interest increasing or decreasing? Biopharmx saw a decrease in short interest in April. As of April 30th, there was short interest totaling 1,090,000 shares, a decrease of 6.8% from the previous total of 1,170,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Biopharmx's short interest compare to its competitors? Here is how the short interest of companies in the sector of "medical" compare to Biopharmx: Kinnate Biopharma Inc. (2.01%), Vistagen Therapeutics, Inc. (5.27%), NGM Biopharmaceuticals, Inc. (4.52%), NervGen Pharma Corp. (0.67%), Assembly Biosciences, Inc. (1.17%), Syros Pharmaceuticals, Inc. (9.89%), vTv Therapeutics Inc. (6.11%), BeyondSpring Inc. (9.99%), ProQR Therapeutics (0.50%), AVROBIO, Inc. (0.37%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: AbbVie Inc. ($7.01 billion), Charter Communications, Inc. ($4.31 billion), Match Group, Inc. ($2.95 billion), The Charles Schwab Co. ($2.81 billion), Tesla, Inc. ($2.69 billion), Microchip Technology Incorporated ($2.59 billion), Wayfair Inc. ($2.19 billion), Snap Inc. ($1.99 billion), The Clorox Company ($1.97 billion), and International Flavors & Fragrances Inc. ($1.92 billion). View all of the most shorted stocks. What does it mean to sell short Biopharmx stock? Short selling BPMX is an investing strategy that aims to generate trading profit from Biopharmx as its price is falling. BPMX shares are trading down $0.64 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Biopharmx? A short squeeze for Biopharmx occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of BPMX, which in turn drives the price of the stock up even further. How often is Biopharmx's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including BPMX, twice per month. The most recent reporting period available is April, 30 2020. More Short Interest Resources from MarketBeat Related Companies: Kinnate Biopharma Short Interest Data Vistagen Therapeutics Short Interest Data NGM Biopharmaceuticals Short Interest Data NervGen Pharma Short Interest Data Assembly Biosciences Short Interest Data Syros Pharmaceuticals Short Interest Data vTv Therapeutics Short Interest Data BeyondSpring Short Interest Data ProQR Therapeutics Short Interest Data AVROBIO Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NYSEAMERICAN:BPMX) was last updated on 4/23/2024 by MarketBeat.com Staff From Our PartnersThe A.I. story nobody is telling you (Read ASAP)TradeSmithSHOCKING Crypto Leak…Crypto 101 Mediatop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill PublishingThe Next Nvidia?InvestorPlaceExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersGreat Crypto BullWeiss Ratings